Schonfeld Strategic Advisors’s RxSight RXST Stock Holding History

Schonfeld Strategic Advisors’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.18M	Sell	191,700 -26,975	-12%	-$224K	0.01%	1013
2025 Q4	$2.28M	Sell	218,675 -338,926	-61%	-$3.4M	0.01%	828
2025 Q3	$5.01M	Buy	557,601 +292,595	+110%	+$2.57M	0.03%	589
2025 Q2	$3.45M	Buy	265,006 +100,037	+61%	+$1.5M	0.02%	716
2025 Q1	$4.17M	Sell	164,969 -34,431	-17%	-$1.02M	0.03%	589
2024 Q4	$6.86M	Buy	+199,400	New	+$8.99M	0.04%	408
2024 Q3	–	Sell	-48,004	Closed	-$2.89M	–	2371
2024 Q2	$2.89M	Sell	48,004 -116,102	-71%	-$6.63M	0.02%	747
2024 Q1	$8.46M	Sell	164,106 -24,789	-13%	-$1.22M	0.06%	438
2023 Q4	$7.62M	Buy	188,895 +79,995	+73%	+$2.35M	0.05%	421
2023 Q3	$3.04M	Sell	108,900 -38,000	-26%	-$1.13M	0.02%	697
2023 Q2	$4.23M	Buy	146,900 +23,500	+19%	+$523K	0.04%	535
2023 Q1	$2.06M	Buy	123,400 +75,600	+158%	+$1.07M	0.02%	678
2022 Q4	$606K	Buy	+47,800	New	+$581K	0.01%	1424

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Schonfeld Strategic Advisors's RXST Position: Q1 2026 in Review

Schonfeld Strategic Advisors reduced its RxSight (RXST) stake by 12% in Q1 2026, selling an estimated $224K and leaving 191,700 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #1013.

Schonfeld Strategic Advisors first reported a position in RXST in Q4 2022 and has held it in 13 quarters since. The position peaked at $8.46M in Q1 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

Schonfeld Strategic Advisors held 191,700 shares of RxSight worth $1.18M as of Q1 2026.
Schonfeld Strategic Advisors sold 26,975 RxSight shares in Q1 2026, an estimated $224K.
RxSight made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1013 holding.
Schonfeld Strategic Advisors first reported a position in RxSight in Q4 2022 and has held it in 13 quarters since.
Schonfeld Strategic Advisors's RxSight position peaked at $8.46M in Q1 2024.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.